ESC Premium Access

Thromboembolic prevention after TAVI: antiplatelets or anticoagulants?

Event: ESC CONGRESS 2016
Topic: Non coronary cardiac interventions
Session type: Debate Session
Date: 29 August 2016
Time: 14:00 - 15:30

Congress Session

5 presentations in this session

Thromboembolic prevention after TAVI: antiplatelets or anticoagulants? Positioning of the topic

Speaker: Professor R. Mehran (New York, US)
Thumbnail

All we need are antiplatelet agents – PRO

Speaker: Doctor A. Colombo (Milan, IT)
Thumbnail

All we need are antiplatelet agents – CON

Speaker: Professor L. Soendergaard (Copenhagen, DK)
Thumbnail

All we need are antiplatelet agents – Discussion PRO/CONTRA.

Thumbnail

Thromboembolic prevention after TAVI: antiplatelets or anticoagulants? - Conclusion

Speaker: Professor S. Windecker (Bern, CH)
Thumbnail

4 speakers from this session

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)
31 presentations
4 followers

Doctor Antonio Colombo

EMO-GVM Heart Center Columbus, Milan (Italy)
10 presentations
0 follower

Professor Lars Soendergaard

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
15 presentations
0 follower

Professor Stephan Windecker

Bern University Hospital, Inselspital, Bern (Switzerland)
29 presentations
6 followers

This platform is supported by

logo Novo Nordisk